Subscribe to Newsletter

Cataract

Business & Profession Cataract

Lightbulb Moment: The Future Reality of Artificial Intelligence

| Julian Upton | 11 min read

The Ophthalmologist’s 2024 Power Listers set out their predictions for AI’s growing role in diagnostics, patient care, and practice management

Subspecialties Cataract

Rising Star: Arjan Hura

| Julian Upton | 4 min read

Arjan Hura talks about choosing ophthalmology over a career in neurology and the mentors who encouraged his move

Subspecialties Cataract

ANTERION®: Advancing Topography, Tomography, and Biometry

| Sponsored by Heidelberg Engineering

Anterior segment specialist James Lewis talks about why ANTERION® is "most exciting piece of equipment he has acquired in the last decade"

Subspecialties Cataract

The Ophthalmologist’s Time Machine: Chapter 18

| Christopher T. Leffler, Charles E. Letocha, Stephen G. Schwartz, Andrzej Grzybowski | 3 min read

Aspiration of cataract in Philadelphia in 1815

Business & Profession Health Economics and Policy

Nobility’s True Badge

| Alun Evans | 5 min read

How one faith-based charity is delivering oceanbound eye care to Sub-Saharan Africa

Business & Profession Pediatric

“Prioritize Pediatric Programs”

| Alun Evans | 5 min read

Isac Vasco da Gama discusses his plans to ensure that all children in Mozambique have access to quality eye care

Business & Profession Basic & Translational Research

The Ophthalmologist Power List 2024 is Live!

| Julian Upton | 3 min read

Our annual ranking of the most inspirational and influential clinicians, scientist, and leaders in ophthalmology

Subspecialties Cataract

Advancing Your Practice with Innovation

| Bonnie An Henderson | 5 min read

Why you should brush up on MSICS with simulation-based cataract surgery training

Business & Profession Cataract

Rising Star: Eric Rosenberg

| Julian Upton | 3 min read

Eric Rosenberg talks about the advancement of digital technology in ophthalmology

Subspecialties Cataract

Treating OSD with Amniotic Membranes

| Zarmeena Vendal | 5 min read

Why amniotic membrane therapy is an increasingly popular option for treating ocular surface disease

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: